Type 3

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 175 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Osteoporosis and the Clinical Laboratory. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Osteoporosis and the Clinical Laboratory (online CE course)
Type 3

Type 3 osteoporosis occurs equally in men and women and at any age. In men, most cases are due to disease or to drug therapy, but in 30% to 45% of affected individuals no cause can be identified. In various series of osteoporotic patients, secondary osteoporosis accounts for about 40% of the total number of osteoporotic fractures seen by a physician.

This type of osteoporosis is associated with many conditions, including hormonal imbalances (eg, Cushing's syndrome), cancer (multiple myeloma), gastrointestinal disorders (inflammatory bowel disease causing malabsorption), drug use (eg, corticosteroids, cancer chemotherapy, anticonvulsants, heparin, barbiturates, valproic acid, gonadotropin-releasing hormone [GnRH], excessive use of aluminum-containing antacids), chronic renal failure, hyperthyroidism, hypogonadism in men, immobilization, osteogenesis imperfecta and related disorders, inflammatory arthritis (particularly rheumatoid arthritis), and poor nutrition (including malnutrition due to eating disorders).